Literature DB >> 32655340

Two Novel Variants and One Previously Reported Variant in the Insulin Receptor Gene in Two Cases with Severe Insulin Resistance Syndrome.

Aydilek Dagdeviren Cakir1, Said Saidov2, Hande Turan1, Serdar Ceylaner3, Yavuz Özer1, Tufan Kutlu4, Oya Ercan1, Olcay Evliyaoglu1.   

Abstract

Donohue syndrome (DS) and Rabson-Mendenhall syndrome (RMS) are rare diseases caused by biallelic variants within the insulin receptor gene (INSR). Here, we report 2 cases: one with DS and the other with RMS. The case with DS presented with intrauterine growth retardation, nipple hypertrophy, clitoromegaly, distended abdomen, hypertrichosis, and dysmorphic features. The second case showed severe acanthosis nigricans, hyperkeratosis, and hypertrichosis. In both cases, abnormal glucose homeostasis due to severe insulin resistance was observed. The diagnosis of DS and RMS was established based on clinical characteristics, abnormal glucose homeostasis, high serum insulin levels, and determination of pathogenic variants in the INSR gene. The first case with DS has 2 novel homozygous variants, NM_000208.3, c.3122delA (p.N1041Mfs*16) and c.3419C>G (p.A1140G), and the second case with RMS has a previously reported homozygous variant NM_000208.3, c.3529+5G>A (IVS19+5G>A) in the INSR gene.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Acanthosis nigricans; Donohue syndrome; INSR; Rabson-Mendenhall syndrome

Year:  2020        PMID: 32655340      PMCID: PMC7325121          DOI: 10.1159/000506722

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  23 in total

1.  Leprechaunism: a euphemism for a rare familial disorder.

Authors:  W L DONOHUE; I UCHIDA
Journal:  J Pediatr       Date:  1954-11       Impact factor: 4.406

Review 2.  Mutations in the insulin receptor and their effect on glucose transport.

Authors:  N Longo; S D Langley; L D Griffin; L J Elsas
Journal:  Trans Assoc Am Physicians       Date:  1992

3.  The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling.

Authors:  Y Ebina; L Ellis; K Jarnagin; M Edery; L Graf; E Clauser; J H Ou; F Masiarz; Y W Kan; I D Goldfine
Journal:  Cell       Date:  1985-04       Impact factor: 41.582

4.  Six cases with severe insulin resistance (SIR) associated with mutations of insulin receptor: Is a Bartter-like syndrome a feature of congenital SIR?

Authors:  Valeria Grasso; Carlo Colombo; Valeria Favalli; Alfonso Galderisi; Ivana Rabbone; Sara Gombos; Enzo Bonora; Ornella Massa; Franco Meschi; Franco Cerutti; Dario Iafusco; Riccardo Bonfanti; Carla Monciotti; Fabrizio Barbetti
Journal:  Acta Diabetol       Date:  2013-07-04       Impact factor: 4.280

Review 5.  Genetic syndromes of severe insulin resistance.

Authors:  Robert K Semple; David B Savage; Elaine K Cochran; Phillip Gorden; Stephen O'Rahilly
Journal:  Endocr Rev       Date:  2011-05-02       Impact factor: 19.871

6.  Severe progressive obstructive cardiomyopathy and renal tubular dysfunction in Donohue syndrome with decreased insulin receptor autophosphorylation due to a novel INSR mutation.

Authors:  Tinka Hovnik; Nevenka Bratanič; Katarina Trebušak Podkrajšek; Jernej Kovač; Darja Paro; Tomaž Podnar; Nataša Bratina; Tadej Battelino
Journal:  Eur J Pediatr       Date:  2012-12-11       Impact factor: 3.183

7.  Donohue syndrome in a neonate with homozygous deletion of exon 3 of the insulin receptor gene.

Authors:  Sevim Unal; Zehra Aycan; David J Halsall; A Esin Kibar; Sevda Eker; Eda Ozaydin
Journal:  J Pediatr Endocrinol Metab       Date:  2009-07       Impact factor: 1.634

8.  Sequencing analysis of insulin receptor defects and detection of two novel mutations in INSR gene.

Authors:  O Ardon; M Procter; T Tvrdik; N Longo; R Mao
Journal:  Mol Genet Metab Rep       Date:  2014-02-11

9.  A Mutation in INSR in a Child Presenting with Severe Acanthosis Nigricans.

Authors:  Hale Tuhan; Serdar Ceylaner; Özlem Nalbantoğlu; Sezer Acar; Ayhan Abacı; Ece Böber; Korcan Demir
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-06-30

10.  Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance.

Authors:  Fiona M Regan; Rachel M Williams; Anna McDonald; A Margot Umpleby; Carlo L Acerini; Stephen O'Rahilly; Roman Hovorka; Robert K Semple; David B Dunger
Journal:  J Clin Endocrinol Metab       Date:  2010-03-16       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.